Export 2757 results:
Author [ Title(Asc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
A. Veitz-Keenan, Barna, J. Ann, Strober, B., Matthews, A. G., Collie, D., Vena, D., Curro, F. A., and Thompson, V. P., “Treatments for hypersensitive noncarious cervical lesions: a Practitioners Engaged in Applied Research and Learning (PEARL) Network randomized clinical effectiveness study.”, J Am Dent Assoc, vol. 144, no. 5, pp. 495-506, 2013.
A. Veitz-Keenan, Barna, J. A., Strober, B., Matthews, A. G., Collie, D., Vena, D., Curro, F. A., and Thompson, V. P., “Treatments for Hypersensitive Noncarious Cervical Lesions: A Practitioners Engaged in Applied Research and Learning (PEARL) Network Randomized Clinical Effectiveness Study”, J Am Dent Assoc, vol. 144, pp. 495-506, 2013.
O. Gasser, Bihl, F., Sanghavi, S., Rinaldo, C., Rowe, D., Hess, C., Stablein, D., Roland, M., Stock, P., and Brander, C., “Treatment-dependent loss of polyfunctional CD8+ T-cell responses in HIV-infected kidney transplant recipients is associated with herpesvirus reactivation.”, Am J Transplant, vol. 9, no. 4, pp. 794-803, 2009.
O. Gasser, Bihl, F., Sanghavi, S., Rinaldo, C., Rowe, D., Hess, C., Stablein, D., Roland, M., Stock, P., and Brander, C., “Treatment-Dependent Loss of Polyfunctional Cd8+ T-Cell Responses in HIV-Infected Kidney Transplant Recipients Is Associated with Herpesvirus Reactivation”, Am J Transplant, vol. 9, pp. 794-803, 2009.
K. A. Holtz, Szefer, E., Noonan, V. K., Kwon, B. K., and Mills, P. B., “Treatment patterns of in-patient spasticity medication use after traumatic spinal cord injury: a prospective cohort study.”, Spinal Cord, vol. 56, no. 12, pp. 1176-1183, 2018.
J. M. Sorensen, Vena, D. A., Fallavollita, A., Chun, H. G., and Cheson, B. D., “Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute: five-year follow-up report.”, J Clin Oncol, vol. 15, no. 2, pp. 458-65, 1997.
V. DA, “Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute; 5-year follow-up report,”, J Clin Oncol, vol. 15, 1997.
E. Atallah, Bylow, K., Troy, J., and Saber, W., “Treatment of older patients with high-risk myelodysplastic syndromes (MDS): the emerging role of allogeneic hematopoietic stem cell transplantation (Allo HSCT).”, Curr Hematol Malig Rep, vol. 9, no. 1, pp. 57-65, 2014.
E. Atallah, Bylow, K., Troy, J., and W, S., “Treatment of Older Patients with High-Risk Myelodysplastic Syndromes (MDS): the Emerging Role of Allogeneic Hematopoietic Stem Cell Transplantation (Allo HSCT)”, Curr Hematol Malig Rep, vol. 9, pp. 57-65, 2014.
R. B. Nussenblatt, Fortin, E., Schiffman, R., Rizzo, L., Smith, J., Van Veldhuisen, P., Sran, P., Yaffe, A., Goldman, C. K., Waldmann, T. A., and Whitcup, S. M., “Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial.”, Proc Natl Acad Sci U S A, vol. 96, no. 13, pp. 7462-6, 1999.
R. B. Nussenblatt, Fortin, E., Schiffman, R., Rizzo, L., Smith, J., Van Veldhuisen, P., Sran, P., Yaffe, A., Goldman, C. K., Waldmann, T. A., and Whitcup, S. M., “Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: A phase I/II clinical trial”, Proceedings of the National Academy of Science USA, vol. 96, pp. 7462-66, 1999.
J. Smith, Thompson, D., Whitcup, S., Suhler, E., Clarke, G., Robinson, M., and Baron, K., “The treatment of JRA-associated uveitis with Etanercept”, 2002.
B. D. Cheson, Sorensen, J. M., Vena, D. A., Montello, M. J., Barrett, J. A., Damasio, E., Tallman, M., Annino, L., Connors, J., Coiffier, B., and Lauria, F., “Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients.”, J Clin Oncol, vol. 16, no. 9, pp. 3007-15, 1998.
W. T. Wong, Dresner, S., Forooghian, F., Glaser, T., Doss, L., Zhou, M., Cunningham, D., Shimel, K., Harrington, M., Hammel, K., Cukras, C. A., Ferris, F. L., and Chew, E. Y., “Treatment of geographic atrophy with subconjunctival sirolimus: results of a phase I/II clinical trial.”, Invest Ophthalmol Vis Sci, vol. 54, no. 4, pp. 2941-50, 2013.
W. T. Wong, Dresner, S., Forooghian, F., Glaser, T., Doss, L., Zhou, M., Cunningham, D., Shimel, K., Harrington, M., Hammel, K., Cukras, C., Ferris, F. L., and Chew, E. Y., “Treatment of Geographic Atrophy with Subconjunctival Sirolimus: Results of a Phase I/II Clinical Trial”, Invest Ophthalmol Vis Sci, vol. 54, pp. 2941-2950, 2013.
G. Gensler, Clemons, T. E., Domalpally, A., Danis, R. P., Blodi, B., Wells, J., Rauser, M., Hoskins, J., G Hubbard, B., Elman, M. J., Fish, G. E., Brucker, A., Margherio, A., and Chew, E. Y., “Treatment of Geographic Atrophy with Intravitreal Sirolimus: The Age-Related Eye Disease Study 2 Ancillary Study.”, Ophthalmol Retina, vol. 2, no. 5, pp. 441-450, 2018.
W. T. Wong, Kam, W., Cunningham, D., Harrington, M., Hammel, K., Meyerle, C. B., Cukras, C., Chew, E. Y., Sadda, S. V. R., and Ferris, F. L., “Treatment of geographic atrophy by the topical administration of OT-551: results of a phase II clinical trial.”, Invest Ophthalmol Vis Sci, vol. 51, no. 12, pp. 6131-9, 2010.
W. Wong, Kam, W., Cunningham, D., Harrington, M., Hammel, K., Meyerle, C., Cukras, C., Chew, E., Sadda, S., and Ferris, F., “Treatment of Geographic Atrophy by the Topical Administration of OT-551: Results of a Phase II Clinical Trial”, Invest Ophthlmol Vis Sci, vol. 51, pp. 613-619, 2010.
J. M. Palefsky, Lee, J. Y., Jay, N., Goldstone, S. E., Darragh, T. M., Dunlevy, H. A., Rosa-Cunha, I., Arons, A., Pugliese, J. C., Vena, D., Sparano, J. A., Wilkin, T. J., Bucher, G., Stier, E. A., Gomez, M. Tirado, Flowers, L., Barroso, L. F., Mitsuyasu, R. T., Lensing, S. Y., Logan, J., Aboulafia, D. M., Schouten, J. T., de la Ossa, J., Levine, R., Korman, J. D., Hagensee, M., Atkinson, T. M., Einstein, M. H., Cracchiolo, B. M., Wiley, D., Ellsworth, G. B., Brickman, C., and J Berry-Lawhorn, M., “Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer.”, N Engl J Med, vol. 386, no. 24, pp. 2273-2282, 2022.
J. Alexander, Metze, T., Goodman, H., McIntosh, M., Zeng, L., Cardi, M., Austin, J., Goel, S., Safdar, S., Greenburg, N., and Woodle, E., “Transplant Success and Immunodulating Diets”, 2003.
R. Leslie, Lewis, M., Shmueli-Blumberg, D., and Jelstrom, E., “Transitioning to the Remote Collection of Urine Specimens for Urine Drug Screening During COVID-19”. 2021.
L. Revoredo, Lewis, M., Shmueli-Blumberg, D., and Jelstrom, E., “Transitioning to the Remote Collection of Urine Specimens for Urine Drug Screening During COVID-19.”, in Society for Clinical Trials (SCT) Annual Conference, Virtual, 2021.
C. Kim, King, D., Chamberlain, J., Clemons, T., and Brandt, D., “Transitioning Paper to Electronic Case Report Forms Mid-Study From One Clinical Research Organization to Another”, in The Society for Clinical Trials 33rd Annual Meeting, Miami, FL, 2012.
J. Harris, Chaney, K., Salazar, D., Ward, A., and Shmueli-Blumberg, D., “Transition from On-Site to Remote Site Initiation Activities”, in Society of Clinical Research Associates (SOCRA), Virtual, 2021.
A. W. Heldman, DiFede, D. L., Fishman, J. E., Zambrano, J. P., Trachtenberg, B. H., Karantalis, V., Mushtaq, M., Williams, A. R., Suncion, V. Y., McNiece, I. K., Ghersin, E., Soto, V., ,, Da Silva, J., Anderson, E., Schwarz, R., Mendizabal, A., and Hare, J. M., “Transendocardial Mesenchymal Stem Cells and Mononuclear Bone Marrow Cells for Ischemic Cardiomyopathy: The TAC-HFT Randomized Trial”, JAMA, vol. 311, pp. 62-73, 2014.